Literature DB >> 6975480

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

A B Roberts, M A Anzano, L C Lamb, J M Smith, M B Sporn.   

Abstract

Proteins potentiated by epidermal growth factor (EGF) to induce a transformed phenotype in non-neoplastic rat kidney fibroblasts in cell culture have been isolated from many non-neoplastic tissues of the adult mouse, including submaxillary gland, kidney, liver, muscle, heart, and brain. They resemble previously described transforming growth factors (TGFs) isolated from neoplastic cells as follows: they are extractable by acid/ethanol and are acid-stable, low molecular weight (6000-10,000) polypeptides requiring disulfide bonds for activity; and they cause anchorage-independent growth of non-neoplastic indicator cells that will not grow in soft agar in their absence. Partial purification of these TGFs from submaxillary glands of male mice shows that they are distinct from EGF. Unlike previously described extracellular TGFs, but like certain cellular TGFs from neoplastic cells, they are potentiated by EGF in their ability to promote anchorage-independent growth. The isoelectric point of the submaxillary gland TGF protein is near neutrality. Chromatography on Bio-Gel P-30 followed by high-pressure liquid chromatography has resulted in a 22,000-fold overall purification. The most purified protein is active in inducing growth in soft agar at 1 ng/ml when assayed in the presence of EGF. The data add further evidence to the concept that neoplasia may result from a quantitative, rather than qualitative, alteration in non-neoplastic biochemical processes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975480      PMCID: PMC348740          DOI: 10.1073/pnas.78.9.5339

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

4.  Radioimmunoassay of epidermal growth factor.

Authors:  R L Byyny; D N Orth; S Cohen
Journal:  Endocrinology       Date:  1972-05       Impact factor: 4.736

5.  Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator.

Authors:  R Montesano; C Drevon; T Kuroki; L Saint Vincent; S Handleman; K K Sanford; D DeFeo; I B Weinstein
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

6.  Efficient detection of soft agar grown colonies using a tetrazolium salt.

Authors:  W I Schaeffer; K Friend
Journal:  Cancer Lett       Date:  1976-05       Impact factor: 8.679

7.  Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor.

Authors:  G Carpenter; L King; S Cohen
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

8.  Cellular tumorigenicity in nude mice. Test of associations among loss of cell-surface fibronectin, anchorage independence, and tumor-forming ability.

Authors:  P Kahn; S I Shin
Journal:  J Cell Biol       Date:  1979-07       Impact factor: 10.539

9.  Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.

Authors:  D DeFeo; M A Gonda; H A Young; E H Chang; D R Lowy; E M Scolnick; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  196 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 3.  TGF-β superfamily: how does it regulate testis development.

Authors:  Yun-Shu Fan; Yan-Jun Hu; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2011-09-27       Impact factor: 2.316

Review 4.  Kidney epithelial cells release growth factors in response to extracellular signals.

Authors:  F G Toback; M M Walsh-Reitz; S R Mendley; S Kartha
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

5.  TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.

Authors:  E A Grimm; W L Crump; A Durett; J P Hester; S Lagoo-Deenadalayan; L B Owen-Schaub
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.

Authors:  E Helseth; G Unsgaard; A Dalen; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

7.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 8.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis.

Authors:  S Mitsue; M Hamanoue; G Tanabe; Y Ogura; S Yoshidome; T Aikou; T Nakamura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Development of a retroviral vector for inducible expression of transforming growth factor beta 1.

Authors:  M L McGeady; P M Arthur; M Seidman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.